NCT01857362View on ClinicalTrials.gov

Bioequivalence of Orfadin 20 mg Compared to Orfadin 10 mg Capsules.

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Healthy
Interventions
DRUG

Nitisinone 20 mg

Nitisinone 20 mg capsules

DRUG

Nitisinone 10 mg

Nitisinone 10 mg capsules

Trial Locations (1)

9471 GP

Pharmaceutical Research Associates Group B.V (PRA), Zuidlaren

Sponsors
All Listed Sponsors
lead

Swedish Orphan Biovitrum

INDUSTRY